No mainstream insurer in the USA or Europe covers stem-cell therapy for diabetes; proven insulin and oral agents are covered instead. Stem-cell therapy is self-pay, sometimes framed as 'personalised medicine' to justify the price. Some academic trials enrol without charge — research-grade, not commercial treatment.
Indicative European costs are roughly €4,000–€8,000 per course, reflecting cell expansion, purity testing, and frequently multiple infusions. Type 1 protocols may add immune-monitoring; Type 2 protocols often bundle metabolic assessment and follow-up. For context, insulin and monitoring supplies cost roughly €100–€300 monthly and are proven — the stem-cell figure is indicative and unproven.
Sunt un candidat? → · Diabetes (Type 1 & 2): full overview → · Cost Diabet (Tip 1 & 2) → · Cost →
Revizuit medical de echipa editorială a StemCellAtlas cu Dr Polina Krasenova (Haematologist · Clinical Haematology & Integrative Oncology · 15+ yrs cell therapy) ale clinicii partenere Stem Plus (Sofia), în funcție de orientările ISSCR, FDA și EMA. Educational information, not medical advice; figures indicative.
Medicină regenerativă certificată GMP în inima UE — de la 3.000–8.000 €, o fracțiune din prețurile din SUA sau Germania. Protocoale personalizate pentru pacienți din peste 50 de țări.
Evaluare medicală gratuită